Micro Developing Active

礼来扩大 Zepbound 的可及性以实现长期增长

评分
0.5
动能
▲ 0.0
文章
9
来源
4

摘要

如果一篇文章讨论礼来公司扩大Zepbound的可及性及其长期增长前景，则该文章属于此叙述。

相关文章

Jim Cramer Likes Eli Lilly’s (LLY) New Deal

Yahoo Finance · 四月 05, 2026
Mixed

Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight

Nasdaq · 四月 04, 2026
Mixed

Eli Lilly secures long-awaited FDA approval for its obesity pill. Here's what to know

CNBC · 四月 01, 2026
Mixed

The cutthroat battle for the US weight-loss drug market

BBC Business · 三月 23, 2026
Mixed

Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook

Yahoo Finance · 三月 22, 2026
Mixed

来源

Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of … Nasdaq
Jim Cramer Likes Eli Lilly’s (LLY) New Deal Yahoo Finance
Is Eli Lilly and Company (LLY) The Best Pharma Stock … Yahoo Finance
Eli Lilly secures long-awaited FDA approval for its obesity pill. … CNBC
Eli Lilly reaches $2.75 billion deal with Insilico to bring … CNBC
Here's How Much Upside Eli Lilly Stock Has, According to … Yahoo Finance
The cutthroat battle for the US weight-loss drug market BBC Business
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing … Yahoo Finance

时间线

最后更新 三月 22, 2026